{
    "title": "108_s1881",
    "content": "The Act may be cited as the \"Medical Devices Technical Corrections Act\" and includes technical corrections regarding Public Law 107-250. The \"Medical Devices Technical Corrections Act\" amends Part 3 of the Federal Food, Drug, and Cosmetic Act by making changes to various sections related to fees for medical devices, including requirements for substantial clinical data in premarket applications. The \"Medical Devices Technical Corrections Act\" amends Part 3 of the Federal Food, Drug, and Cosmetic Act by making changes to various sections related to fees for medical devices, including requirements for substantial clinical data in premarket applications under section 351 of the Public Health Service Act. In paragraph (8), the definition of \"affiliate\" is expanded to include relationships with international business entities. The \"Medical Devices Technical Corrections Act\" amends Part 3 of the Federal Food, Drug, and Cosmetic Act by making changes to various sections related to fees for medical devices. The \"Medical Devices Technical Corrections Act\" amends Part 3 of the Federal Food, Drug, and Cosmetic Act by making changes to various sections related to fees for medical devices, including adjustments to application and reporting requirements for firms. The \"Medical Devices Technical Corrections Act\" amends regulations for medical devices, including adjustments to fees and inspections by accredited persons. The \"Medical Devices Technical Corrections Act\" updates regulations for medical devices, specifically regarding inspections of establishments manufacturing class II or class III devices. The \"Medical Devices Technical Corrections Act\" updates regulations for inspections of establishments manufacturing class II or class III devices, including addressing financial conflicts of interest between accredited persons and device establishment owners. The \"Medical Devices Technical Corrections Act\" updates regulations for inspections of device establishments, including addressing financial conflicts of interest between accredited persons and owners. The \"Medical Devices Technical Corrections Act\" updates regulations for inspections of device establishments, including addressing financial conflicts of interest between accredited persons and owners. In clause (iii), conditions for inspections are modified to include accredited persons authorized by the Secretary. Clause (iv)(I) also undergoes changes in the first sentence. In clause (iv)(I), changes are made to inspections of device establishments, including specifying inspections during the previous 4 years and adding \"section\" after \"pursuant to.\" Additionally, the requirement for a commercial reason for a waiver is removed, and the timeframe for granting waivers is adjusted. In clause (iv)(II), amendments are made to inspectional findings of device establishments, including adding \"of a device establishment required to register\" after \"to be conducted\" and inserting \"section\" after \"pursuant to.\" Furthermore, adjustments are made to the description of compliance with sections 501 and 502, and the term \"inspections\" is replaced with \"inspectional findings.\" In paragraph (6)(B)(iv), amendments allow the Secretary to suspend inspections by accredited persons if a device establishment is found to be substantially non-compliant within two years of clearance under subparagraph (A). The text chunk discusses amendments to the Federal Food, Drug, and Cosmetic Act regarding the number of inspections conducted by accredited persons and Federal employees in device establishments. It also addresses corrections related to prohibited acts. The text chunk discusses amendments to the Federal Food, Drug, and Cosmetic Act related to noncompliance with inspection report requirements and electronic labeling for in vitro diagnostic devices. Amendments to the Federal Food, Drug, and Cosmetic Act include changes to inspection report requirements and premarket notification timelines. Amendments to the Federal Food, Drug, and Cosmetic Act involve technical corrections and redesignating paragraphs in section 515. Amendments to the Federal Food, Drug, and Cosmetic Act involve changes related to safety issues and technical corrections in section 738(a). Amendments to the Federal Food, Drug, and Cosmetic Act involve changes related to safety issues and technical corrections in section 738(a). The changes include redefining types of fees and clarifying the language in the section. Amendments to the Federal Food, Drug, and Cosmetic Act involve changes in section 738, including redefining fees and clarifying language. Amendments include updating subsection references for premarket applications. Amendments to section 738 of the Federal Food, Drug, and Cosmetic Act involve updating subsection references for premarket applications. This includes changing subsection (a)(1)(A)(vii) to (a)(2)(A)(vii) and (a)(1)(A)(i) to (a)(2)(A)(i). Amendments were made to Public Law 107-250, including updating subsection references and conforming amendments. The Secretary of Health and Human Services is required to submit a report on barriers to the availability of devices for children within 180 days of the enactment of the Act. The report will include recommendations from the Secretary of Health and Human Services for changes to encourage the invention and development of devices. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}